CIK 0001055726 · Non-accelerated filer<br>Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330969592
- Phone
- 8584103134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-26 | Sumner Michael John Chief Medical Officer | Option exercise · Restricted Stock Unit | −5,010 | 5,009 | ||
| 2026-02-26 | Sumner Michael John Chief Medical Officer | Option exercise · Restricted Stock Unit | −11,550 | 23,100 | ||
| 2026-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise | +18,632 | 78,317 | ||
| 2026-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −8,057 | $1.79 | $14K | 70,260 |
| 2026-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise | +28,401 | 98,661 | ||
| 2026-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −13,657 | $1.79 | $24K | 85,004 |
| 2026-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise · Restricted Stock Unit | −18,632 | 18,631 | ||
| 2026-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise · Restricted Stock Unit | −28,401 | 56,800 | ||
| 2026-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise | +5,010 | 37,632 | ||
| 2026-02-26 | Humeau Laurent Chief Scientific Officer | Shares withheld for taxes | −2,064 | $1.79 | $4K | 35,568 |
| 2026-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise | +7,366 | 42,934 | ||
| 2026-02-26 | Humeau Laurent Chief Scientific Officer | Shares withheld for taxes | −3,034 | $1.79 | $5K | 39,900 |
| 2026-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise · Restricted Stock Unit | −5,010 | 5,009 | ||
| 2026-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise · Restricted Stock Unit | −7,366 | 14,732 | ||
| 2026-02-26 | Weiner David B. Director | Option exercise | +972 | 87,592 | ||
| 2026-02-26 | Weiner David B. Director | Option exercise · Restricted Stock Unit | −972 | 0 | ||
| 2026-02-26 | KIES PETER CFO | Option exercise | +5,010 | 35,267 | ||
| 2026-02-26 | KIES PETER CFO | Shares withheld for taxes | −2,965 | $1.79 | $5K | 32,302 |
| 2026-02-26 | KIES PETER CFO | Option exercise | +10,634 | 42,936 | ||
| 2026-02-26 | KIES PETER CFO | Shares withheld for taxes | −6,294 | $1.79 | $11K | 36,642 |
Page 4 of 17 · 322 trades